StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a report published on Saturday. The brokerage issued a sell rating on the stock.
Ampio Pharmaceuticals Stock Performance
NYSE:AMPE opened at $0.00 on Friday. The company has a market cap of $2,964.00, a price-to-earnings ratio of 0.00 and a beta of 3.71. The stock’s fifty day moving average price is $0.02 and its two-hundred day moving average price is $0.02. Ampio Pharmaceuticals has a 52-week low of $0.00 and a 52-week high of $2.47.
Ampio Pharmaceuticals Company Profile
Further Reading
- Five stocks we like better than Ampio Pharmaceuticals
- How to Invest in Biotech Stocks
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- What is a Dividend King?
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- What is the S&P/TSX Index?
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
